Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid irrigation to reduce blood loss during mini-percutaneous nephrolithotomy
TCTR20211021003Phase 0Not yet recruiting
- Sponsor
- N/A
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 0, randomised trial of tranexamic acid in nephrolithiasis (2 arms), sponsored by N/A. Primary endpoint: Perioperative blood loss. Planned start Oct 2021; status: not yet recruiting.
02
Drugs
tranexamic acid
03
Conditions
nephrolithiasis
Beyond the preview
Go deeper on TCTR20211021003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20211021003.